Arcadia Biosciences Registers Resale of 11.9M Shares, Potential 546% Dilution
RKDA is trading near its 52-week low of $0.65 (6.1% above the low).
Summary
Arcadia Biosciences filed an S-3 to register the resale of 11.9 million shares from a recent private placement, representing a potential 546% dilution for existing shareholders, amidst ongoing financial distress.
Key Events · Financing and Capital Events · RKDA
-
Massive Potential Dilution
The company registered 11,922,333 shares for resale, which, if fully issued, would represent a 546% increase over the current 2,181,715 outstanding shares.
-
Resale by Selling Stockholders
The shares are being registered for resale by investors who acquired pre-funded warrants and options in a $4 million private placement that closed on June 12, 2026.
-
Limited Company Proceeds from Resale
Arcadia Biosciences will not receive any proceeds from the actual sale of shares by the selling stockholders, only from the cash exercise of the underlying options, which could total up to $7.4 million.
-
Context of Financial Distress
This significant potential dilution occurs while the company has reiterated a 'going concern' warning, reported a $4.4 million net loss in Q1 2026, and disclosed a $4.0 million debt default.
Analysis · RKDA · Energy & Transportation
Arcadia Biosciences has filed an S-3 registration statement for the resale of up to 11,922,333 shares of common stock by selling stockholders. These shares originate from pre-funded warrants and options issued in a $4 million private placement completed on June 12, 2026. This registration represents a potential dilution of approximately 546% to existing shareholders, as the current outstanding shares are 2,181,715. While the company could receive up to $7.4 million from the cash exercise of these options, the primary impact is the creation of a massive share overhang, which is highly negative for a company already facing a 'going concern' warning, recurring net losses, and a debt default.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RKDA was trading at $0.69 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $0.65 to $6.71. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.